Akero Therapeutics
AKRO
AKRO
113 hedge funds and large institutions have $329M invested in Akero Therapeutics in 2022 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 40 increasing their positions, 29 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
4.35% more ownership
Funds ownership: 100.52% → 104.87% (+4.4%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
34% less capital invested
Capital invested by funds: $499M → $329M (-$170M)
Holders
113
Holding in Top 10
3
Calls
$111K
Puts
$69K
Top Buyers
| 1 | +$9.5M | |
| 2 | +$4.3M | |
| 3 | +$4.28M | |
| 4 |
YCM
Yiheng Capital Management
San Francisco,
California
|
+$3.12M |
| 5 |
LFCM
Long Focus Capital Management
San Juan,
Puerto Rico
|
+$2.74M |
Top Sellers
| 1 | -$14.5M | |
| 2 | -$8.77M | |
| 3 | -$7.05M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$2.84M |
| 5 |
Rafferty Asset Management
New York
|
-$957K |